James H. Reamer

Array ( [id] => 4397498 [patent_doc_number] => 06297286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Therapeutic use and formulation' [patent_app_type] => 1 [patent_app_number] => 9/708813 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 3039 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297286.pdf [firstpage_image] =>[orig_patent_app_number] => 708813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596581 [patent_doc_number] => 06492410 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer' [patent_app_type] => B1 [patent_app_number] => 09/674818 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8965 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492410.pdf [firstpage_image] =>[orig_patent_app_number] => 09674818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1383809 [patent_doc_number] => 06552005 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Molecular chemotherapy enhancement of radiotherapy' [patent_app_type] => B1 [patent_app_number] => 09/706190 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 20515 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552005.pdf [firstpage_image] =>[orig_patent_app_number] => 09706190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514976 [patent_doc_number] => 06420424 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'CCR-3 receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/674208 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5199 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420424.pdf [firstpage_image] =>[orig_patent_app_number] => 09674208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353501 [patent_doc_number] => 06291502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions' [patent_app_type] => 1 [patent_app_number] => 9/695920 [patent_app_country] => US [patent_app_date] => 2000-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1898 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291502.pdf [firstpage_image] =>[orig_patent_app_number] => 695920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433180 [patent_doc_number] => 06340469 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'System for prophylactic treatment of mammary disorders' [patent_app_type] => B1 [patent_app_number] => 09/694676 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2472 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340469.pdf [firstpage_image] =>[orig_patent_app_number] => 09694676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475188 [patent_doc_number] => 06387936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Combinations of riluzole and levodopa for the treatment of Parkinson\'s disease' [patent_app_type] => B1 [patent_app_number] => 09/694860 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387936.pdf [firstpage_image] =>[orig_patent_app_number] => 09694860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1111311 [patent_doc_number] => 06806257 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-19 [patent_title] => 'Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators' [patent_app_type] => B1 [patent_app_number] => 09/693130 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 47 [patent_no_of_words] => 18550 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/806/06806257.pdf [firstpage_image] =>[orig_patent_app_number] => 09693130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490899 [patent_doc_number] => 06417234 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Nordihydroguaiaretic derivatives for use in treatment of tumors' [patent_app_type] => B1 [patent_app_number] => 09/690063 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 33 [patent_no_of_words] => 12486 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417234.pdf [firstpage_image] =>[orig_patent_app_number] => 09690063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305364 [patent_doc_number] => 06326373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'JAK-3 inhibitors for treating allergic disorders' [patent_app_type] => 1 [patent_app_number] => 9/688755 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 54 [patent_no_of_words] => 20409 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326373.pdf [firstpage_image] =>[orig_patent_app_number] => 688755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460057 [patent_doc_number] => 06391888 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Topical anesthetics useful for treating cancer' [patent_app_type] => B1 [patent_app_number] => 09/687389 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3517 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391888.pdf [firstpage_image] =>[orig_patent_app_number] => 09687389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320415 [patent_doc_number] => 06248744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Method for the treatment of pain, including chronic and female specific pain' [patent_app_type] => 1 [patent_app_number] => 9/622675 [patent_app_country] => US [patent_app_date] => 2000-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11278 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248744.pdf [firstpage_image] =>[orig_patent_app_number] => 622675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4382757 [patent_doc_number] => 06294524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Use of ergosterol and its apparent compounds for stimulating the proliferation of skin cells' [patent_app_type] => 1 [patent_app_number] => 9/508899 [patent_app_country] => US [patent_app_date] => 2000-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2266 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294524.pdf [firstpage_image] =>[orig_patent_app_number] => 508899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643841 [patent_doc_number] => 06429198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Compositions for increasing athletic performance in mammals' [patent_app_type] => B1 [patent_app_number] => 09/677639 [patent_app_country] => US [patent_app_date] => 2000-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7148 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429198.pdf [firstpage_image] =>[orig_patent_app_number] => 09677639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416569 [patent_doc_number] => 06511970 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium' [patent_app_type] => B1 [patent_app_number] => 09/672735 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36170 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511970.pdf [firstpage_image] =>[orig_patent_app_number] => 09672735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446971 [patent_doc_number] => 06369095 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Indole-3-carbinol (13C) derivatives and methods' [patent_app_type] => B1 [patent_app_number] => 09/672641 [patent_app_country] => US [patent_app_date] => 2000-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10052 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369095.pdf [firstpage_image] =>[orig_patent_app_number] => 09672641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4329319 [patent_doc_number] => 06319943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Oral formulation for paclitaxel' [patent_app_type] => 1 [patent_app_number] => 9/665890 [patent_app_country] => US [patent_app_date] => 2000-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7637 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319943.pdf [firstpage_image] =>[orig_patent_app_number] => 665890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446004 [patent_doc_number] => 06368638 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Process of making an aqueous calcium carbonate suspension' [patent_app_type] => B1 [patent_app_number] => 09/623710 [patent_app_country] => US [patent_app_date] => 2000-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3337 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368638.pdf [firstpage_image] =>[orig_patent_app_number] => 09623710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581532 [patent_doc_number] => 06423691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytography' [patent_app_type] => B1 [patent_app_number] => 09/623393 [patent_app_country] => US [patent_app_date] => 2000-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4054 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423691.pdf [firstpage_image] =>[orig_patent_app_number] => 09623393 [rel_patent_id] =>[rel_patent_doc_number] =>)